|
|
|
This is the preliminary program for the 2007 Joint Statistical
Meetings in Salt Lake City, Utah.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2007 Program page |
= Applied Session,
= Theme Session,
= Presenter| 296 | Tue, 7/31/07, 12:30 PM - 1:50 PM | CC-Ballroom A |
| Biopharmaceutical Section Roundtables with Lunch (fee event) - Roundtables - with Lunch | ||
|
Biopharmaceutical Section |
||
| Organizer(s): Kaylan Ghosh, Vislation | ||
| TL10: |
Joining the Evil Empire: What It's Like To Move from Academics to Industry —  Robert Parker, Amgen Inc.
|
|
| TL11: |
Statistical Analysis Plans: How, When, Why, and for Whom Do We Do Them? — Bruce Binkowitz, Merck & Co., Inc.
|
|
| TL12: |
JAMA Policy on Independent Analysis and Public Trust — Hong Liu-Seifert, Eli Lilly and Company
|
|
| TL13: |
Blinded Sample Size Re-estimation — Biao Xing, Genentech, Inc.
|
|
| TL14: |
Estimation of Treatment Effects in Randomized Trials with Noncompliance and Crossover: Why ITT Analysis May Not Be Our Best Option — Afisi S. Ismaila, McMaster University; Stephen Walter, McMaster University
|
|
|
JSM 2007
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |